Yoshitaka Iba

965 total citations
31 papers, 697 citations indexed

About

Yoshitaka Iba is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Epidemiology. According to data from OpenAlex, Yoshitaka Iba has authored 31 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Yoshitaka Iba's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Influenza Virus Research Studies (7 papers) and Protein purification and stability (7 papers). Yoshitaka Iba is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Influenza Virus Research Studies (7 papers) and Protein purification and stability (7 papers). Yoshitaka Iba collaborates with scholars based in Japan, United States and France. Yoshitaka Iba's co-authors include Yoshikazu Kurosawa, Nobuko Ohshima, Yoshinobu Okuno, Ritsuko Kubota‐Koketsu, Wataru Ito, Peter S. Lee, Robyn L. Stanfield, Wenli Yu, Ian A. Wilson and Yoshizo Asano and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Yoshitaka Iba

29 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshitaka Iba Japan 13 363 318 298 173 103 31 697
Beth A. Wurzburg United States 9 352 1.0× 389 1.2× 379 1.3× 403 2.3× 67 0.7× 10 953
Homer Pantua United States 11 339 0.9× 186 0.6× 268 0.9× 88 0.5× 113 1.1× 19 746
A. T. Baker Australia 6 368 1.0× 460 1.4× 496 1.7× 153 0.9× 53 0.5× 7 835
Jody Manischewitz United States 11 259 0.7× 136 0.4× 156 0.5× 305 1.8× 70 0.7× 14 559
Lawrence Horowitz United States 6 520 1.4× 249 0.8× 179 0.6× 238 1.4× 118 1.1× 7 672
Richard Chubet United States 7 126 0.3× 131 0.4× 299 1.0× 78 0.5× 151 1.5× 8 542
Laura Zarebski Argentina 7 129 0.4× 260 0.8× 487 1.6× 281 1.6× 87 0.8× 7 697
Ted Kwaks Netherlands 13 794 2.2× 286 0.9× 596 2.0× 335 1.9× 212 2.1× 15 1.3k
G. Florent Belgium 11 263 0.7× 180 0.6× 229 0.8× 185 1.1× 66 0.6× 25 619
Aryn A. Price United States 7 214 0.6× 117 0.4× 250 0.8× 138 0.8× 56 0.5× 8 623

Countries citing papers authored by Yoshitaka Iba

Since Specialization
Citations

This map shows the geographic impact of Yoshitaka Iba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Iba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Iba more than expected).

Fields of papers citing papers by Yoshitaka Iba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Iba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Iba. The network helps show where Yoshitaka Iba may publish in the future.

Co-authorship network of co-authors of Yoshitaka Iba

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Iba. A scholar is included among the top collaborators of Yoshitaka Iba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Iba. Yoshitaka Iba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hattori, Yasuhiro, Nobuko Ohshima, Yu Taniguchi, et al.. (2025). 22O Development of anti-CD38-CAR allogeneic γδ T cells as an off-the-shelf use for myeloma. ESMO Open. 10. 104179–104179.
2.
Kubo, Takanori, Seiji Nagano, Takahiko Miyama, et al.. (2023). Anti-CD38-CAR IPS-Derived Cytotoxic T Lymphocytes Efficiently Eliminate Myeloma Cells Treated with Daratumumab and Isatuximab in Vitro and In Vivo. Blood. 142(Supplement 1). 3312–3312. 1 indexed citations
3.
Ohshima, Nobuko, Yoshitaka Iba, Ritsuko Kubota‐Koketsu, et al.. (2020). Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines. International Journal of Molecular Sciences. 21(19). 7422–7422.
4.
Ukai, Yoshinori, Yoshitaka Iba, Nobuko Ohshima, et al.. (2018). Isolation of human monoclonal antibodies that bind to two different antigens and are encoded by germline VH and VL genes. Biochemical and Biophysical Research Communications. 503(2). 1141–1147. 1 indexed citations
5.
Ohshima, Nobuko, Ritsuko Kubota‐Koketsu, Yoshitaka Iba, Yoshinobu Okuno, & Yoshikazu Kurosawa. (2014). Two Types of Antibodies Are Induced by Vaccination with A/California/2009pdm Virus: Binding near the Sialic Acid-Binding Pocket and Neutralizing Both H1N1 and H5N1 Viruses. PLoS ONE. 9(2). e87305–e87305. 9 indexed citations
6.
Lee, Peter S., Nobuko Ohshima, Robyn L. Stanfield, et al.. (2014). Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus. Nature Communications. 5(1). 3614–3614. 166 indexed citations
7.
Okada, Jun, Nobuko Ohshima, Ritsuko Kubota‐Koketsu, et al.. (2010). Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man. Journal of General Virology. 92(2). 326–335. 16 indexed citations
8.
Okada, Jun, Nobuko Ohshima, Ritsuko Kubota‐Koketsu, et al.. (2009). Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968–1973, 1977–1993 and 1997–2003. Virology. 397(2). 322–330. 22 indexed citations
9.
Kitamura, Yuka, Gene Kurosawa, Miho Tanaka, et al.. (2009). Frequent overexpression of CADM1/IGSF4 in lung adenocarcinoma. Biochemical and Biophysical Research Communications. 383(4). 480–484. 10 indexed citations
10.
Ohta, Akane, Tsugiya Murayama, Yoshitaka Iba, et al.. (2009). Recombinant human monoclonal antibodies to human cytomegalovirus glycoprotein B neutralize virus in a complement-dependent manner. Microbes and Infection. 11(13). 1029–1036. 12 indexed citations
11.
Kurosawa, Gene, Yasushi Akahori, Kazuki Matsuda, et al.. (2009). Methods for comprehensive identification of membrane proteins recognized by a large number of monoclonal antibodies. Journal of Immunological Methods. 351(1-2). 1–12. 12 indexed citations
12.
Akahori, Yasushi, Gene Kurosawa, Miwa Morita, et al.. (2008). Isolation of antigen/antibody complexes through organic solvent (ICOS) method. Biochemical and Biophysical Research Communications. 378(4). 832–835. 17 indexed citations
13.
Furutani, Masahiro, Tokuro Iwabuchi, Toshii Iida, et al.. (2004). Expression of foreign proteins in Escherichia coli by fusing with an archaeal FK506 binding protein. Applied Microbiology and Biotechnology. 64(1). 99–105. 22 indexed citations
14.
Akahori, Yasushi, et al.. (2001). Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression. Journal of Immunological Methods. 257(1-2). 175–184. 52 indexed citations
15.
Miyazaki, Chie, Yoshitaka Iba, Yukio Yamada, et al.. (1999). Changes in the specificity of antibodies by site-specific mutagenesis followed by random mutagenesis. Protein Engineering Design and Selection. 12(5). 407–415. 29 indexed citations
16.
Iba, Yoshitaka & Yoshikazu Kurosawa. (1997). Comparison of strategies for the construction of libraries of artificial antibodies. Immunology and Cell Biology. 75(2). 217–221. 9 indexed citations
17.
Iba, Yoshitaka, Wataru Ito, & Yoshikazu Kurosawa. (1997). Expression vectors for the introduction of highly diverged sequences into the six complementarity-determining regions of an antibody. Gene. 194(1). 35–46. 22 indexed citations
18.
Kaneko, Takashi, Yoshitaka Iba, K Zenita, et al.. (1993). Preparation of Mouse-Human Chimeric Antibody to an Embryonic Carbohydrate Antigen, Lewis Y. The Journal of Biochemistry. 113(1). 114–117. 9 indexed citations
19.
Inoue, Yoshiharu, Yoshitaka Iba, Hiroshi Yano, Kousaku Murata, & Akira Kimura. (1993). Functional analysis of the ?-glutamylcysteine synthetase of Escherichia coli B: effect of substitution of His-150 to Ala. Applied Microbiology and Biotechnology. 38(4). 473–7. 2 indexed citations
20.
Murata, Kousaku, Yoshitaka Iba, Yoshiharu Inoue, & Akira Kimura. (1988). L-leucine and its analogue: Specific inhibitors for S-benzyl-L-cysteine-p-nitroanilide-hydrolyzing enzyme in Escherichia coli B. Biochemical and Biophysical Research Communications. 153(2). 767–772. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth A. Wurzburg Breakdown of academic impact, for papers by Homer Pantua Breakdown of academic impact, for papers by A. T. Baker Breakdown of academic impact, for papers by Jody Manischewitz Breakdown of academic impact, for papers by Lawrence Horowitz Breakdown of academic impact, for papers by Richard Chubet Breakdown of academic impact, for papers by Laura Zarebski Breakdown of academic impact, for papers by Ted Kwaks Breakdown of academic impact, for papers by G. Florent Breakdown of academic impact, for papers by Aryn A. Price
Rankless by CCL
2026